1GLOBAL and Odido Redefine On-Demand 5G Connectivity With SimWallet
AMSTERDAM — 1GLOBAL, a technology-driven global mobile communications provider, has partnered with leading Dutch mobile operator Odido to power the launch of SimWallet, a standalone mobile app for eSIM connectivity. SimWallet was introduced into the Dutch market in April this year. It provides near-instant access to Odido's 5G network in the Netherlands and can be used by anyone, regardless of whether they are an Odido customer.
Article content
Once installed, users can connect to Odido's state-of-the-art 5G network for unlimited internet for 24 hours, multiple days or up to 30 days, enjoying fixed low rates that work on their smartphone, tablet, laptop or any eSIM-capable device.
Article content
Rapid integration with intelligent API technology
Article content
SimWallet utilizes 1GLOBAL's API technology, which is directly integrated into the Odido network. By utilizing a multi-IMSI (International Mobile Subscriber Identity) architecture, 1GLOBAL can dynamically allocate IMSIs to users on demand, enabling seamless eSIM provisioning and connectivity activation. This integration ensures that customers that use SimWallet can do so without consuming any of their paid data, making pricing clearer and more affordable for customers.
Article content
Odido's SimWallet app launched four weeks after initial API integration began, showcasing 1GLOBAL's ability to empower mobile network operators and digital-first businesses so they can implement go-to-market strategies quickly, accurately, and securely.
Article content
' What drives Odido to innovate is our commitment to breaking industry conventions on behalf of customers,' said Tisha van Lammeren, Chief Commercial Officer Mass Market at Odido. ' Our new SimWallet app does just that, and it is thanks to our technology partner 1GLOBAL that we are able to offer truly on-demand 5G access, seamlessly.' 'At 1GLOBAL, we are always excited to be innovative and deliver new pathways to customer connectivity,' said Hakan Koç, Founder and CEO of 1GLOBAL. 'The Odido SimWallet is one of the solutions that showcase our key position to meet the rising demand for temporary but immediate 5G access. Our advanced API technology enables clients like Odido to offer frictionless, on-brand eSIMs that keep their customers connected and engaged, helping them unlock high-margin, recurring revenue streams.' 1GLOBAL is the ideal partner for global eSIM connectivity As an internationally connected partner, 1GLOBAL is perfectly positioned to support forward-thinking companies like Odido in growing their service offering and boosting customer enjoyment.
Article content
1GLOBAL is supported by ten Mobile Virtual Network Operators (MVNOs), five international roaming partners, and over 150 interconnects, enabling unrivalled connectivity on a global scale. It is also one of only five telcos worldwide that operates its own fully GSMA-accredited SM-DP+ platform that is integral to the distribution of eSIMs.
Article content
Read more about 1GLOBAL's innovative white label eSIM solutions for digital-first businesses. About 1GLOBAL: Leading Digital Transformation in Telecommunications 1GLOBAL is a technology-driven global mobile communications provider dedicated to empowering enterprises worldwide to unlock the full growth potential of mobile connectivity. With a best-in-class telecom technology platform, a comprehensive suite of globally viable regulatory licenses, and privileged access to the telecom wholesale market, 1GLOBAL is uniquely positioned to deliver seamless compliance and connectivity solutions. Serving the world's leading banks, corporations, and digital-first businesses—including neo-banks, travel companies, and payment service providers—1GLOBAL connects over 43 million devices globally.
Article content
With 2024 full-year revenue exceeding US$100 million, 1GLOBAL is a profitable business generating significant cash flows to fund its ongoing investments in infrastructure, transformation, and growth. 2024 saw major client wins and marked 1GLOBAL's evolution from a multi-market telecommunication provider to a global technology-driven mobile connectivity powerhouse.
Article content
Established in 2022 by experienced tech founders and entrepreneurs Hakan Koç and Pyrros Koussios, 1GLOBAL is a European technology leader driving digital transformation in the global telecommunications market. It operates as a fully regulated Mobile Virtual Network Operator ('MVNO') in nine countries and as a regulated telecommunications operator in an additional 31 countries. Headquartered in the Netherlands, with world-class R&D hubs in Lisbon, Berlin, and São Paulo, 1GLOBAL employs over 450 experts across 13 countries.
Article content
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
9 hours ago
- Globe and Mail
Intas & Accord signs Agreement to acquire Prothya Biosolutions
AHMEDABAD, India , Aug. 11, 2025 /CNW/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire 100% of Prothya Biosolutions Belgium BV and each of its subsidiaries, a leading plasma-derived medicinal products (PDMP) business based primarily in the Netherlands and Belgium . Subject to the satisfaction of customary closing conditions, including regulatory clearances, the deal is anticipated to close shortly. This proposed acquisition marks a significant step in Intas and Accord's long-standing ambition to establish a global presence in the PDMP market, expanding Intas's established leadership in India into a truly international footprint. Prothya Biosolutions, with primary operations in Amsterdam and Brussels and plasma collection centres across Hungary , employs approximately 1,200 people. The company is one of Europe's largest plasma fractionators. Formed in 2021 through the integration of Plasma Industries Belgium, originally linked to the Belgian Red Cross, and Sanquin Plasma Products, formerly a part of the Sanquin Blood Supply Foundation, Prothya brings over 60 years of experience in plasma collection and the development of PDMPs. Binish Chudgar , Chairman of Intas & Accord, stated: "We are delighted to expand our plasma business through the acquisition of Prothya Biosolutions. Combined with our fractionation capabilities in India , this positions us to create a truly global plasma platform—serving patients worldwide with critical, often under-prescribed, therapies." Intas's plasma division in India has been supplying hospitals with PDMPs since 2015, supported by an annual fractionation capacity of over 1 million litres and exports to multiple international markets. Additional capacity is due to come online with the expansion of Intas's Gujarat-based facility. Nir Epstein , CEO of Prothya, commented: "Over the past four years, we've expanded into new markets, advanced critical therapies, established our own plasma collection network in Hungary , and supplied plasma derivatives to some of the world's leading PDMP companies—all while building a stronger, more resilient organization. I want to thank our dedicated team for their unwavering commitment to our patients. I believe Accord is the right company to support Prothya and its people in the next phase of growth and global expansion." The global market for PDMPs—particularly IVIG (intravenous immunoglobulin)—is currently valued at $30 billion and is expected to reach $50 billion by 2035. This acquisition will give Intas access to significant additional fractionation capacity, supported by Accord's commercial footprint spanning 85 countries. BofA Securities is acting as the exclusive financial advisor to Accord in this transaction. Evercore is acting as the exclusive financial advisor to Prothya in this transaction. About Intas: Intas Pharmaceuticals Ltd. is a leading vertically integrated pharmaceutical company based in Ahmedabad, India , having end-to-end capabilities of formulation development, manufacturing, and marketing along with backward integration of APIs. Intas also has strong in-house biosimilar development and marketing capabilities, with more than 15 products being marketed. Intas is committed to expanding global healthcare access by providing affordable, high-quality medications through strategic partnerships and extensive R&D investment to meet the diverse needs of healthcare systems around the world. Intas has set up a network of subsidiaries, under the umbrella name of Accord Healthcare, to operate in global markets. Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations year on year. It is currently present in more than 85 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America , Europe , Central & Latin America , Asia-Pacific as well as CIS and MENA countries. Intas's remarkable success in North America and European operations has helped us emerge as a global brand in the world's largest pharmaceutical markets.
CTV News
9 hours ago
- CTV News
Bell to provide customers free access to Perplexity Pro for a year in latest AI move
Bell Canada is partnering with Perplexity, an AI-powered conversational search engine, to give its customers a year of free artificial intelligence services. The Perplexity website and logo are shown in this photo, in New York, Friday, July 5, 2024. (AP Photo/Richard Drew) MONTREAL — Bell Canada is partnering with Perplexity, an AI-powered conversational search engine, to give its customers a year of free artificial intelligence services. It marks another step in the telecommunications company's foray into the AI space, having also signed a deal last month with Cohere to provide full-stack sovereign AI solutions for government and business customers. Bell says its partnership with Perplexity will give eligible cellphone and internet customers access to Perplexity Pro, which is valued at nearly $300 for yearly subscriptions. Perplexity Pro provides customers the ability to use AI models such as GPT-5, Claude 4.0 and Gemini 2.5 Pro, which can support tasks ranging from research and writing, to content planning and data analysis. Mobile customers will receive codes to redeem their free subscription in the coming days via email, text and their MyBell accounts, while internet customers will receive access starting this fall. Bell's venture into AI also includes Bell AI Fabric, a project announced in May to support Canadian businesses' and governments' AI needs, with a plan to open six AI data centres providing around 500 megawatts of hydroelectric-powered compute capacity. This report by The Canadian Press was first published Aug. 11, 2025. BNN Bloomberg, CTV News and CP24 are owned by Bell Media, which is a division of BCE.
Winnipeg Free Press
9 hours ago
- Winnipeg Free Press
Nvidia, AMD to pay 15% of China chip sale revenue to U.S. government
NEW YORK (AP) — Nvidia and AMD agreed to share 15% of their revenues from chip sales to China with the U.S. government, a U.S. government official has confirmed. President Donald Trump's administration had halted the sale of advanced computer chips to China back in in April, but Nvidia and AMD revealed in July that Washington would allow them to resume sales of the H20 and MI308 chips, which are used in artificial intelligence development. The official, who insisted on anonymity to discuss a policy not yet formally announced, confirmed to The Associated Press the revenue sharing terms of the deal, and said the broad strokes of the initial report by The Financial Times were accurate. The FT reports that Nvidia and AMD agreed to the financial arrangement as a condition for obtaining export license to resume sales to China. 'We follow rules the U.S. government sets for our participation in worldwide markets. While we haven't shipped H20 to China for months, we hope export control rules will let America compete in China and worldwide,' Nvidia wrote in a statement to the AP. 'America cannot repeat 5G and lose telecommunication leadership. America's AI tech stack can be the world's standard if we race.' Wednesdays What's next in arts, life and pop culture. AMD did not immediately reply to a request for comment. Restrictions on sales of advanced chips to China have been central to the AI race between the world's two largest economic powers, but such controls are also controversial. Proponents argue that these restrictions are necessary to slow China down enough to allow U.S. companies to keep their lead. Meanwhile, opponents say the export controls have loopholes — and could still spur innovation. The emergence of China's DeepSeek AI chatbot in January particularly renewed concerns over how China might use advanced chips to help develop its own AI capabilities.
